ProfileGDS5822 / ILMN_1245012
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 13% 23% 3% 40% 29% 42% 12% 2% 38% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.113
GSM1276600PDAC Late Ablation Control 215.523
GSM1276601PDAC Late Ablation Control 31.43
GSM1276602PDAC Late Ablation 116.140
GSM1276603PDAC Late Ablation 214.729
GSM1276604PDAC Late Ablation 320.242
GSM1303940PDAC Late Ablation_anti-CTLA4 110.112
GSM1303941PDAC Late Ablation_anti-CTLA4 22.32
GSM1303942PDAC Late Ablation_anti-CTLA4 318.238